Biological indices in the assessment of breast cancer.
作者信息
Leong A S, Lee A K
机构信息
Division of Tissue Pathology, Institute of Medical and Veterinary Science and Department of Pathology, University of Adelaide, Adelaide, South Australia.
出版信息
Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221.
Abstract
摘要
相似文献
1
Biological indices in the assessment of breast cancer.评估乳腺癌的生物学指标。
Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221.
2
Can diffusion tensor anisotropy indices assist in breast cancer detection?扩散张量各向异性指数能否辅助乳腺癌检测？
J Magn Reson Imaging. 2016 Dec;44(6):1624-1632. doi: 10.1002/jmri.25292. Epub 2016 Apr 19.
3
Fatigue screening in breast cancer patients: identifying likely cases of cancer-related fatigue.乳腺癌患者的疲劳筛查：识别可能的癌症相关性疲劳病例。
Psychooncology. 2016 Mar;25(3):275-81. doi: 10.1002/pon.3907. Epub 2015 Jul 22.
4
The Clinical Importance of Measurement of Hematological Indices in the Breast Cancer Survivals: A Comparison Between Premenopausal and Postmenopausal Women.血液学指标测量在乳腺癌幸存者中的临床重要性：绝经前和绝经后女性的比较
World J Oncol. 2016 Feb;7(1):1-4. doi: 10.14740/wjon956e. Epub 2016 Apr 3.
5
6
Prognostic immune-related gene models for breast cancer: a pooled analysis.乳腺癌的预后免疫相关基因模型：一项汇总分析。
Onco Targets Ther. 2017 Sep 11;10:4423-4433. doi: 10.2147/OTT.S144015. eCollection 2017.
7
Immunohistochemical Ki-67/KL1 double stains increase accuracy of Ki-67 indices in breast cancer and simplify automated image analysis.免疫组织化学Ki-67/KL1双重染色提高了乳腺癌中Ki-67指数的准确性，并简化了自动图像分析。
Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):568-76. doi: 10.1097/PAI.0b013e3182a84b99.
8
Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients.乳腺癌和结直肠癌患者尿液氧化指标的比较评估
J Cancer Res Clin Oncol. 2009 Feb;135(2):319-23. doi: 10.1007/s00432-008-0462-7. Epub 2008 Aug 29.
9
Understanding Changes in Tumor Texture Indices in PET: A Comparison Between Visual Assessment and Index Values in Simulated and Patient Data.了解PET中肿瘤纹理指数的变化：模拟数据和患者数据中视觉评估与指数值的比较
J Nucl Med. 2017 Mar;58(3):387-392. doi: 10.2967/jnumed.116.181859. Epub 2016 Oct 6.
10
Three gold indicators for breast cancer prognosis: a case-control study with ROC analysis for novel ratios related to CBC with (ALP and LDH).乳腺癌预后的三个黄金指标：一项病例对照研究，采用ROC分析评估与伴（碱性磷酸酶和乳酸脱氢酶）全血细胞计数相关的新比率。
Mol Biol Rep. 2019 Apr;46(2):2013-2027. doi: 10.1007/s11033-019-04650-9. Epub 2019 Jan 31.
引用本文的文献
1
Assessment of breast cancer immunohistochemistry and tumor characteristics in Nigeria.尼日利亚乳腺癌免疫组化及肿瘤特征评估
World J Clin Oncol. 2020 Nov 24;11(11):935-944. doi: 10.5306/wjco.v11.i11.935.
2
The changing role of pathology in breast cancer diagnosis and treatment.病理学在乳腺癌诊断和治疗中的角色变化。
Pathobiology. 2011;78(2):99-114. doi: 10.1159/000292644. Epub 2011 Jun 14.
本文引用的文献
1
Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study.表皮生长因子受体与人类乳腺癌预后：一项前瞻性研究。
Breast Cancer Res Treat. 1993;25(1):21-7. doi: 10.1007/BF00662397.
2
In primary human breast carcinomas mutations in exons 5 and 6 of the p53 gene are associated with a high S-phase index.在原发性人类乳腺癌中，p53基因外显子5和6的突变与高S期指数相关。
Int J Cancer. 1993 Jun 19;54(4):531-5. doi: 10.1002/ijc.2910540402.
3
p53 as an independent prognostic marker in lymph node-negative breast cancer patients.p53作为淋巴结阴性乳腺癌患者的独立预后标志物。
J Natl Cancer Inst. 1993 Jun 16;85(12):965-70. doi: 10.1093/jnci/85.12.965.
4
Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumours.配对的原发性和转移性人类肿瘤中p53癌蛋白的免疫化学分析。
Eur J Cancer. 1993;29A(6):881-6. doi: 10.1016/s0959-8049(05)80431-9.
5
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.癌蛋白MDM2掩盖了肿瘤抑制因子p53的激活结构域。
Nature. 1993 Apr 29;362(6423):857-60. doi: 10.1038/362857a0.
6
A linkage study in seven breast cancer families.对七个乳腺癌家族的连锁研究。
Am J Hum Genet. 1993 Apr;52(4):786-8.
7
Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21.家族性乳腺-卵巢癌基因在17q12-q21染色体上的遗传异质性与定位
Am J Hum Genet. 1993 Apr;52(4):767-76.
8
9
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.冰岛人群中人类乳腺癌的体细胞p53突变：一种预后因素。
Cancer Res. 1993 Apr 1;53(7):1637-41.
10
Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells.RB和p53基因在人乳腺癌细胞中的肿瘤抑制活性。
Oncogene. 1993 Feb;8(2):279-88.
Zotero 插件